Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Topic
Biotech Funding
Topic
Biotech Funding
Basecamp Research Lands $140m as AI Drug Design Draws Big Pharma Money
Basecamp Research closed an oversubscribed $140m Series C led by S32, with NVIDIA and Anthropic participating, as Roche opened a…
Biotech Startups Raised $9.1B in H1 2026, But Seed Funding Lagged
Biotechs banked $9.1B in H1 2026, the best first half since 2022 — but 42 of the rounds went to companies already in human testin…
Enveda Doubles Valuation to $2B in $311M Series E Round
AI drug discovery startup Enveda raised $311M at a $2B valuation, double its worth from a year ago, to push nature-derived drug c…